Spironolactone disappoints in preserved-EF heart failure: Aldo-DHF in print TheHeart.Org Chicago, IL - A year of aldosterone blockade failed to improve exercise capacity, symptoms, or quality-of-life measures in a placebo-controlled trial of >400 patients with heart failure and LV ejection fractions >50% [1]. However, spironolactone ... |
